Psychedelics Company Numinus Wellness Consolidates Recent Surge Higher: What’s Going On?
Numinus Wellness, Inc (OTC: NUMIF) was consolidating about 2% lower on Wednesday after surging over 30% on Tuesday.
Psyched: Psychedelics In Davos, Prince Harry In The 90s, Cathie Wood’s Latest Moves And More
Psychedelics Take Center Stage In Davos
Psychedelics will lead the conversation inside the Davos House of Health for a second year in a row this January.
‘New York Governor Signs Bill To Mandate State Legalization Of Schedule I Drugs Like Psilocybin And MDMA If Federal Law Changes’ – Marijuana Moment
https://www.marijuanamoment.net/new-york-governor-signs-bill-to-mandate-state-legalization-of-schedule-i-drugs-like-psilocybin-and-mdma-if-federal-law-changes/
The governor of New York recently signed legislation
Cathie Wood Reacts To Atai’s Drastic Stock Plunge After Doomed Clinical Study Results
After atai Life Sciences (NASDAQ: ATAI) shared the results of subsidiary Perception Neuroscience’s Phase 2 trial of R-ketamine compound for TRD, the psyche
‘Lawmakers Are Already Pursuing Psychedelics Legislation In Nearly A Dozen States For 2023: From Connecticut to California, bipartisan lawmakers are signaling strong interest in reforming laws around natural plants and fungi.’ -Marijuana Moment
https://www.marijuanamoment.net/lawmakers-are-already-pursuing-psychedelics-legislation-in-nearly-a-dozen-states-for-2023/
These Are The 11 Biggest Psychedelics News And Trends You May Have Missed Last Year
What a year for psychedelics!
Psychedelic Stock Gainers And Losers From December 30, 2022
GAINERS: ATAI Life Sciences (NASDAQ:ATAI) shares closed up 3.50% at $2.66 GH Research (NASDAQ:GHRS) shares closed up 3.23%…
Marijuana Moment Tweets: New York Lawmakers File Psychedelics Legalization Bill For 2023:
https://twitter.com/MarijuanaMoment/status/1608865148336324608
‘California Senator Files Revised Psychedelics Legalization Bill For 2023 – Leaving Out LSD, MDMA And Other Synthetics’ – MarijuanaMoment
https://www.marijuanamoment.net/california-senator-files-revised-psychedelics-legalization-bill-for-2023-leaving-out-lsd-mdma-and-other-synthetics/
A California senator has refiled a bill to legalize possession of
EF Hutton Initiates Coverage On Compass Pathways with Buy Rating, Announces Price Target of $38
EF Hutton analyst Elemer Piros initiates coverage on Compass Pathways (NASDAQ:CMPS) with a Buy rating and announces Price Target of $38.